Edesa Biotech Inc.
EDSA | NASDAQ
$4.11
-$0.03 (-0.72%)
At close: Sep 21, 2026, 4:00 PM ET
$4.11
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:48 PM ET
Fiscal Year Period Ending | FY 2025 Sep 29, 2025 | FY 2024 Sep 29, 2024 | FY 2023 Sep 29, 2023 | FY 2022 Sep 29, 2022 | FY 2021 Sep 29, 2021 | FY 2020 Sep 29, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 328.8K |
Cost of Revenue | 119.27K | 186.05K | 183.47K | 118.19K | 118.79K | 17.6K |
Gross Profit | -119.27K | -186.05K | -183.47K | -118.19K | -118.79K | 311.2K |
Operating Income | -7.91M | -7.01M | -9.22M | -18.37M | -23.68M | -6.4M |
Interest Income | 2.56K | 153.5K | 289.85K | 63.52 | 11.17K | 37.78K |
Pretax Income | -7.18M | -6.17M | -8.37M | -17.55M | -13.34M | -6.36M |
Net Income | -7.19M | -6.17M | -8.37M | -17.55M | -13.34M | -6.36M |
Selling & General & Admin | 4.24M | 4.13M | 4.43M | 5.04M | 5.73M | 3.38M |
Research & Development | 3.67M | 2.88M | 4.79M | 13.34M | 17.95M | 3.33M |
Other Expenses | -119.27K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 7.79M | 7.01M | 9.22M | 18.37M | 23.68M | 6.71M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.91M | 7.01M | 9.22M | 18.37M | 23.68M | 6.73M |
Income Tax Expense | 800 | 800 | 800 | 800 | 800 | 800 |
Shares Outstanding (Basic) | 5.68M | 3.2M | 2.86M | 2.1M | 1.73M | 1.23M |
Shares Outstanding (Diluted) | 5.68M | 3.2M | 2.86M | 2.1M | 1.73M | 1.23M |
EPS (Basic) | -1.27 | -1.93 | -2.93 | -8.37 | -7.74 | -5.18 |
EPS (Diluted) | -1.27 | -1.93 | -2.93 | -8.37 | -7.73 | -5.18 |
EBITDA | -7.07M | -5.98M | -8.19M | -17.43M | -13.22M | -6.35M |
EBIT | -7.18M | -6.17M | -8.37M | -17.55M | -13.34M | -6.4M |
Depreciation & Amortization | 119.27K | 186.05K | 183.47K | 118.19K | 118.79K | 57.56K |
Add to Watchlist
Select watchlists to add or remove EDSA